Bonus Biogroup Ltd.是一家生物技术公司,从事干细胞和组织工程领域。该公司正在开发基于自体和同种异体骨植入物的细胞治疗产品,这些产品将实现高效的骨移植,并提供基于细胞的骨替代假体以修复骨损伤。该公司面向全球市场,旨在治疗主要疾病,如与骨骼和软骨相关的关节炎、骨质疏松症,以及各种类型的骨骼和关节创伤,如髋部骨折和膝盖损伤等。2012年4月29日,Bonus Bio Group Ltd.全资收购了Bonus Therapeutic Ltd.
BBIXF stock price ended at $0.15 on 星期三, after rising 50.00%
On the latest trading day Feb 11, 2026, the stock price of BBIXF rose by 50.00%, climbing from $0.15 to $0.15. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $0.15 and a high of $0.15. Alongside this price increase, trading volume also rose by 17.5K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 500 shares were traded, amounting to a market value of approximately --.